High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

NCT07223385 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Diagnosis)
Prostate Cancer Stage IV
CV Risk

Interventions

OTHER: Cardio-Oncology Referral
OTHER: Notification to PCP/General Cardiologist

Sponsor

Cedars-Sinai Medical Center